Öz

Objective: The purpose of our study was to examine the association between endoscopically diagnosed Helicobacter pylori (HP) gastritis and hepatosteatosis, and to investigate the correlation between the presence of HP and biochemical and anthropometric measurements in children.

Materials and Methods: Patients who were followed up in the Pediatric Gastroenterology outpatient clinic of Kayseri City Training and Research Hospital and underwent esophagogastroduodenoscopy performed by the attending gastroenterologist were evaluated. Patients aged between 2 and 18 years, with a histopathological diagnosis of gastritis, both HP positive and negative, were enrolled in the study.

Results: In patients with HP-positive gastritis, the incidence of hepatosteatosis was found to be statistically significantly higher compared to those with HP-negative gastritis (χ² = 22.704; p <0.001). A statistically significant weak positive correlation was found between the density of HP and the grade of hepatosteatosis (rho = 0.344; p <0.001).

Conclusion: The HP-positive gastritis in children is associated with the development of hepatosteatosis, and the higher grade of hepatosteatosis in patients with HP-positive gastritis suggests that HP gastritis may impact the development of fatty liver.

Anahtar Kelimeler: Children, gastritis, Helicobacter pylori, hepatosteatosis

Kaynakça

  1. Oliveros-Bastidas A, Calcagno-Pissarelli MP, Naya M, Ávila-Núñez JL, Alonso-Amelot ME. Human gastric cancer, Helicobacter pylori and bracken carcinogens: A connecting hypothesis. Med Hypotheses. 2016;88:91-9. https://doi.org/10.1016/j.mehy.2015.11.007
  2. Van Veen SJ, Levy EI, Huysentruyt K, Vandenplas Y. Clinical Dilemmas for the Diagnosis and Treatment of Helicobacter pylori Infection in Children: From Guideline to Practice. Pediatr Gastroenterol Hepatol Nutr. 2024;27(5):267-73. https://doi.org/10.5223/pghn.2024.27.5.267
  3. Yuan C, Adeloye D, Luk TT,et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(3):185-94. https://doi.org/10.1016/S2352-4642(21)00400-4
  4. Nguyen J, Kotilea K, Bontems P, Miendje Deyi VY. Helicobacter pylori Infections in Children. Antibiotics (Basel). 2023 Sep 12;12(9):1440. https://doi.org/10.3390/antibiotics12091440
  5. Santos MLC, de Brito BB, da Silva FAF, et al. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol. 2020;26(28):4076-93. https://doi.org/10.3748/wjg.v26.i28.4076
  6. Kim BJ, Kim HS, Jang HJ, Kim JH. Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials. Gastroenterol Res Pract. 2018;2018:6090878. https://doi.org/10.1155/2018/6090878
  7. Xu C, Wu Y, Xu S. Association between Helicobacter pylori infection and growth outcomes in children: A meta-analysis. Helicobacter. 2022;27(1):e12861. https://doi.org/10.1111/hel.12861
  8. Fitzpatrick E, Dhawan A. Childhood and Adolescent Nonalcoholic Fatty Liver Disease: Is It Different from Adults? J Clin Exp Hepatol. 2019;9(6):716-22. https://doi.org/10.1016/j.jceh.2019.05.005
  9. Vcev A, Nakić D, Mrden A, et al. Helicobacter pylori infection and coronary artery disease. Coll Antropol. 2007;31(3):757-60.
  10. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J. 2010;103(3):190-6. https://doi.org/10.1097/SMJ.0b013e3181cf373f
  11. Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int J Mol Sci. 2017;18(8):1649. https://doi.org/10.3390/ijms18081649
  12. Liu R, Liu Q, He Y, et al. Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis. Medicine (Baltimore). 2019;98(44):e17781. https://doi.org/10.1097/MD.0000000000017781
  13. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-90. https://doi.org/10.1002/hep.24452
  14. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010 ;23(4):713-39. https://doi.org/10.1128/CMR.00011-10
  15. Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 2017;64(6):991-1003. https://doi.org/10.1097/MPG.0000000000001594
  16. Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: current status and future concepts. World J Gastroenterol. 2014;20(18):5283-93. https://doi.org/10.3748/wjg.v20.i18.5283
  17. Sierra MS, Hastings EV, Goodman KJ. What do we know about benefits of H. pylori treatment in childhood? Gut Microbes. 2013;4(6):549-67. https://doi.org/10.4161/gmic.27000
  18. Wilson GS, George J. Physical and chemical insults induce inflammation and gastrointestinal cancers. Cancer Lett. 2014;345(2):190-5. https://doi.org/10.1016/j.canlet.2013.07.011
  19. He J, Liu Y, Ouyang Q, et al. Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications. Front Microbiol. 2022;13:972777. https://doi.org/10.3389/fmicb.2022.972777
  20. Xia W, Zhang X, Wang J, Sun C, Wu L. Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. Br J Nutr. 2012;108(2):357-62. https://doi.org/10.1017/S0007114511005666
  21. Chmiela M, Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J Gastroenterol. 2017;23(22):3964-77. https://doi.org/10.3748/wjg.v23.i22.3964
  22. Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018;24(29):3204-21. https://doi.org/10.3748/wjg.v24.i29.3204
  23. Franceschi F, Zuccalà G, Roccarina D, Gasbarrini A. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol. 2014;11(4):234-42. https://doi.org/10.1038/nrgastro.2013.243
  24. Zhou S, Huang Y, Liang B, et al. Systemic and mucosal pre-administration of recombinant Helicobacter pylori neutrophil-activating protein prevents ovalbumin-induced allergic asthma in mice. FEMS Microbiol Lett. 2017;364(2):fnw288. https://doi.org/10.1093/femsle/fnw288
  25. Ahmad HM, Al-Fishawy HS, Shaltout I, Elnaeem EAA, Mohamed AS, Salem AE. A comparative study between current and past Helicobacter pylori infection in terms of microalbuminuria in patients with type 2 diabetes. BMC Infect Dis. 2024;24(1):1091. https://doi.org/10.1186/s12879-024-09918-5
  26. Priyadharshini V, Dhande SK, Hanumanram G, Sanjay Surya GS, Gowri Shankar A. Analysis of the relation between elevated neutrophil lymphocyte ratio, and erythrocyte sedimentation rate in Helicobacter pylori positive chronic gastritis patients. Int JAdv Med. 2022;9(10):1023-6. https://doi.org/10.18203/2349-3933.ijam20222400
  27. Homan M, Jones NL, Bontems P, et al. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr. 2024;79(3):758-85. https://doi.org/10.1002/jpn3.12314
  28. Wei L, Ding HG. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? Medicine (Baltimore). 2021;100(31):e26706. https://doi.org/10.1097/MD.0000000000026706
  29. Fan N, Peng L, Xia Z, Zhang L, Wang Y, Peng Y. Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. Front Microbiol. 2018;9:73. https://doi.org/10.3389/fmicb.2018.00073
  30. Chen X, Fu J, Jin K, et al. Overweight and Helicobacter pylori infection: a correlation in metabolic dysfunction-associated fatty liver disease. Front Cell Infect Microbiol. 2025;15:1565298. https://doi.org/10.3389/fcimb.2025.1565298
  31. Barakat S, Abdel-Fadeel M, Sharaki O, Shafei ME, Elbanna B, Mahfouz A. Is Helicobacter pylori infection a risk factor for non-alcoholic fatty liver disease in children?. Eur J Pediatr. 2024;184(1):47. https://doi.org/10.1007/s00431-024-05867-y
  32. Xu MY, Liu L, Yuan BS, Yin J, Lu QB. Association of obesity with Helicobacter pylori infection: A retrospective study. World J Gastroenterol. 2017;23(15):2750-6. https://doi.org/10.3748/wjg.v23.i15.2750

Telif hakkı ve lisans

Telif hakkı © 2026 Yazar(lar). Açık erişimli bu makale, orijinal çalışmaya uygun şekilde atıfta bulunulması koşuluyla, herhangi bir ortamda veya formatta sınırsız kullanım, dağıtım ve çoğaltmaya izin veren Creative Commons Atıf Lisansı (CC BY) altında dağıtılmıştır.

Nasıl atıf yapılır

1.
Daldaban Sarıca B, Emsal EZ. From stomach to liver: The impact of Helicobacter pylori gastritis onpediatric hepatic steatosis. Turk J Pediatr Dis. 2026;20(3):202-207. https://doi.org/10.12956/TJPD.2025.1263